Neuroprotective agents in acute ischemic strokehttps://www.explorationpub.com/Journals/ent/Article/100437
Acute ischemic stroke (AIS) is the leading cause of disability and one of the top causes of mortality worldwide. The current standard of care is reperfusion therapy including intravenous thrombolysis (IVT) and thrombectomy. However, these treatments have limitations as they have a limited therapeuti...
Main Authors: | Grace YY Chia, Selvie Yeo, Jamie SY Ho, Eric Jou, Leonard LL Yeo, Benjamin YQ Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-02-01
|
Series: | Exploration of Neuroprotective Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/ent/Article/100437 |
Similar Items
-
Neuroprotective Effects of Marine Algae
by: Se-Kwon Kim, et al.
Published: (2011-05-01) -
ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses
by: Canelif Yilmaz, et al.
Published: (2022-03-01) -
Neuroprotective Properties of Chitosan and Its Derivatives
by: Se-Kwon Kim, et al.
Published: (2010-07-01) -
New possibilities of neuroprotection in ischemic stroke
by: D. V. Sergeyev, et al.
Published: (2011-12-01) -
Review: Neuroprotective Nanocarriers in Glaucoma
by: Kun Pei, et al.
Published: (2024-09-01)